US Patent 9308257 Protein formulation
Patent 9308257 was granted and assigned to MedImmune, LLC on April, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+124 characters)
Article
Patent abstract
The present invention provides stable lyophilized formulations of bispecific antibodies or fragments thereof.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Ambarish Shah0
Monika S. Sharma, Sr.0
Scott Hammond0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09308257 Protein formulation US Patent 9308257 Protein formulation
Infobox
Patent Number
093082570
Patent Number
93082570
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
093082570
Date of Patent
April 12, 2016
0Patent Application Number
127447450
Date Filed
November 26, 2008
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09308257 Protein formulation
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09308257
Date of patent
April 12, 2016
Patent application number
12744745
Date Filed
November 26, 2008
Patent primary examiner
Find more entities like US Patent 9308257 Protein formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
